Plenary Session: RWE in European Healthcare Decision Making—What's in It for Patients?

Moderator

Karen Facey, BSc, PhD, Universities of Oxford, Utrecht, Edinburgh and RWE4Decisions, Utrecht, Netherlands

Speakers

Maria Dutarte, European Patients’ Academy on Therapeutic Innovation (EUPATI), Utrecht, Netherlands; Pall Jonsson, BSc, PhD, National Institute for Health and Care Excellence (NICE), Manchester, United Kingdom; Sofie Gustafsson, PhD, Pfizer, Stockholm, Sweden; Renske Los, PhD, Erasmus MC, Rotterdam, Netherlands

Real-World Evidence (RWE) is increasingly shaping healthcare decision-making across Europe, not just for systems and stakeholders, but for the patients they serve. By capturing how treatments perform in everyday settings, RWE offers critical insights into patient outcomes, experiences, and unmet needs. At the heart of European efforts like DARWIN EU, collaborative networks are laying the groundwork for more connected, consistent, and patient-centered evidence generation. These initiatives aim to translate complex real-world data (RWD) into actionable knowledge that improves safety, access, and effectiveness of treatments across diverse patient populations.  This plenary session will discuss the opportunities and challenges of RWE from a multi-stakeholder perspective and will explore how strategic cross-border partnerships and technological advancements—including AI—are helping to realize RWE’s full potential for patients. From regulators to researchers, all stakeholders have a role to play in ensuring that RWE efforts deliver meaningful, measurable value for patients.  

Code

142b

Topic

Health Policy & Regulatory, Patient-Centered Research, Real World Data & Information Systems